Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Parasomnias × Dronabinol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 3 Pain 3 Nausea 3 Pancreatic Neoplasms 2 Breast Neoplasms 2 Parasomnias 1 Neoplasms 1 Marijuana Abuse 1 Malnutrition 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Cancer Pain 1 Brain Neoplasms 1 Anxiety Disorders 1

Interventions

Surveys and Questionnaires 6 Melatonin 4 Yoga 2 Exercise 2 Control Groups 2 nabiximols 1 Walking 1 Ultraviolet Therapy 1 Tai Ji 1 Sugars 1 Respiration 1 Relaxation Therapy 1 Qigong 1 Modafinil 1 Minocycline 1 Mindfulness 1 Massage 1 Exercise Movement Techniques 1 Dronabinol 1 Cannabidiol 1 Breathing Exercises 1 Autogenic Training 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡